These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37246726)

  • 1. Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes.
    Komorita Y; Shiroozu A; Nakamura H
    J Diabetes Investig; 2023 Aug; 14(8):1009-1010. PubMed ID: 37246726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
    He X; Hu X; Ma X; Su H; Ying L; Peng J; Pan X; Bao Y; Zhou J; Jia W
    Cardiovasc Diabetol; 2017 Jun; 16(1):77. PubMed ID: 28619026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
    Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
    Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
    Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes].
    Zagarskikh EY; Proshchai GA; Vorokhobina NV
    Urologiia; 2018 Mar; (1):92-95. PubMed ID: 29634140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes.
    Woo YC; Lee CH; Fong CH; Xu A; Tso AW; Cheung BM; Lam KS
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):37-43. PubMed ID: 27611701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk.
    Berezin AE; Berezin AA
    Diabetes Metab Syndr; 2019; 13(4):2549-2556. PubMed ID: 31405675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
    Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
    Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.
    Jin S; Xia N; Han L
    BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33789910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum/plasma fibroblast growth factor 21 in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang YS; Ye J; Cao YH; Zhang R; Liu Y; Zhang SW; Dai W; Zhang Q
    Postgrad Med J; 2019 Mar; 95(1121):134-139. PubMed ID: 30918117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.
    Gan F; Huang J; Dai T; Li M; Liu J
    Ann Palliat Med; 2020 Mar; 9(2):368-374. PubMed ID: 32268770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes.
    Hu J; Liu Z; Tong Y; Mei Z; Xu A; Zhou P; Chen X; Tang W; Zhou Z; Xiao Y
    Front Endocrinol (Lausanne); 2020; 11():282. PubMed ID: 32528406
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum Levels of Fibroblast Growth Factor 21 Are Positively Associated with Aortic Stiffness in Patients with Type 2 Diabetes Mellitus.
    Huang SY; Wu DA; Tsai JP; Hsu BG
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes.
    Kim WJ; Kim SS; Lee HC; Song SH; Bae MJ; Yi YS; Jeon YK; Kim BH; Kim YK; Kim IJ
    J Korean Med Sci; 2015 May; 30(5):586-90. PubMed ID: 25931789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics.
    Sørensen MH; Bojer AS; Jørgensen NR; Broadbent DA; Plein S; Madsen PL; Gæde P
    Cardiovasc Diabetol; 2020 Sep; 19(1):158. PubMed ID: 32998751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
    Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
    Ong KL; Rye KA; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4701-8. PubMed ID: 23144467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.